JNCASR restores memory in mice with Alzheimer’s


Some of the notable features of this drug: it uses nanotechnology to cross the blood/brain barrier, and it upregulates 81 genes that are underactive in Alzheimer’s to normal levels.

It is in preclinical, which means they have no data for humans, but the technology is very interesting.